<div dir="ltr"><br><div class="gmail_extra"><br><br><div class="gmail_quote">On Wed, Dec 18, 2013 at 9:03 AM, Graham Triggs <span dir="ltr"><<a href="mailto:grahamtriggs@gmail.com" target="_blank">grahamtriggs@gmail.com</a>></span> wrote:<br>
<blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir="ltr"><div class="gmail_extra"><div class="gmail_quote"><div class="im">On 18 December 2013 06:41, Peter Murray-Rust <span dir="ltr"></span></div>
<div>I agree with you about the other problems about funders and OA subset. However, let's just step back a minute and think about the bigger picture.</div><div><br></div><div>An -NC licence does not prevent any scholarly use of the content, which by definition, would be non-commercial. It only covers commercial interests, and purchasing those rights would come from private funds.</div>
</div></div></div></blockquote><div><br></div><div>This is a common misconception. Scholarly is frequently commercial. Universities charge fees - a commercial transaction. Authors pay publishers - a commercial transaction. <br>
<br><br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir="ltr"><div class="gmail_extra"><div class="gmail_quote">
<div><br></div><div>If an -NC licence allowed the authors (funders) to pay a lower APC, with the balance expected to be made up from commercial sales to private funds, then this would reduce the burden of publishing on the public purse, at no harm to scholarly use.</div>
<div><br></div></div></div></div></blockquote><div>Everyone has amateur opinions on what NC allows. What matters is the law - and we have seen publishers exercising the law. The best estimate of the LAW that I have seen is:<br>
<br><a href="http://www.pensoft.net/journals/zookeys/article/2189/">http://www.pensoft.net/journals/zookeys/article/2189/</a><br><br><div class="">ZooKeys 150: 127–149, doi: 10.3897/zookeys.150.2189</div>
<div class="">Creative Commons licenses and the non-commercial condition: Implications for the re-use of biodiversity information</div>
<div class="">Gregor Hagedorn <span class="">1</span>, Daniel Mietchen <span class="">2</span>, Robert A. Morris <span class="">3</span>, Donat Agosti <span class="">4</span>, Lyubomir Penev <span class="">5</span>, Walter G. Berendsohn <span class="">6</span>, Donald Hobern <span class="">7</span><br>
<br></div><div class="">This makes it clear that the law almost certainly prevents re-use in teaching, content-mining , publishing and much other "scholarly" activity. NC has no beneficial spinoffs to scholarship and has serious drawbacks. <br>
<br></div><div class="">Offering it for a lower cost, without explaining the implications, is IMO unacceptable.<br></div> </div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div dir="ltr"><div class="gmail_extra"><div class="gmail_quote"><div></div><div>Arguably, that could be considered a good thing. Although more likely it would be seen that the public expenditure as an investment to allow commercial use to drive economic growth outweighs the small cost difference.</div>
</div></div></div></blockquote><div><br></div><div>a nice idea but fallacious as the opportunity cost is large.<br> <br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div dir="ltr"><div class="gmail_extra"><div class="gmail_quote"><span class=""><font color="#888888">
<div><br></div><div>G </div></font></span></div></div></div>
<br>_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><br>
<br></blockquote></div><br><br clear="all"><br>-- <br>Peter Murray-Rust<br>Reader in Molecular Informatics<br>Unilever Centre, Dep. Of Chemistry<br>University of Cambridge<br>CB2 1EW, UK<br>+44-1223-763069
</div></div>